First human tests begin for potential delirium treatment
NCT ID NCT07422142
Summary
This early-stage study aims to test the safety and how the body processes gastrodin injection in healthy Chinese volunteers. Researchers will give the injection to 54 healthy adults and closely monitor for any side effects. The study will measure how much of the drug gets into the bloodstream, how long it stays, and how the body eliminates it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DELIRIUM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Tianjin, Tianjin Municipality, China
Conditions
Explore the condition pages connected to this study.